Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pedro Veliça
Expression of a Dominant T-Cell Receptor Can Reduce Toxicity and Enhance Tumor Protection of Allogeneic T-Cell Therapy
Haematologica
Hematology
Related publications
Modulating Immunometabolism of Tumor Specific CD8 T Cells to Enhance T Cell Based Therapy for Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Safety of Allogeneic Hematopoietic Cell Transplant in Adults After Cd19 Targeted Chimeric Antigen Receptor-Modified T-Cell (Car-T) Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Antibodies to Costimulatory Receptor 4-1bb Enhance Anti-Tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function
Immunity
Infectious Diseases
Allergy
Immunology
Tumor Gene Therapy by MVA-mediated Expression of T-Cell–stimulating Antibodies
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Receptor-Directed Therapy of T-Cell Leukemias and Lymphomas
Journal of Immunotoxicology
Toxicology
Immunology
Combining CD19 Redirection and Alloanergization to Generate Tumor-Specific Human T Cells for Allogeneic Cell Therapy of B-Cell Malignancies
Cancer Research
Cancer Research
Oncology
Defective Synthesis or Association of T-Cell Receptor Chains Underlies Loss of Surface T-Cell Receptor-Cd3 Expression in Enteropathy-Associated T-Cell Lymphoma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Susceptibility to Cell Death Is a Dominant Phenotype: Triggering of Activation-Driven T-Cell Death Independent of the T-Cell Antigen Receptor Complex.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
29. Redirected Allogeneic T Cells for Adoptive Cell Therapy of Cancer
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
